Link Pharma Chem Limited (BOM:524748)
India
· Delayed Price · Currency is INR 27.79
-1.21 (-4.17%)
At close: Mar 9, 2026
Link Pharma Chem Revenue
Link Pharma Chem had revenue of 67.35M INR in the quarter ending December 31, 2025, with 26.06% growth. This brings the company's revenue in the last twelve months to 272.89M, up 1.00% year-over-year. In the fiscal year ending March 31, 2025, Link Pharma Chem had annual revenue of 254.33M, down -14.93%.
Revenue (ttm)
272.89M
Revenue Growth
+1.00%
P/S Ratio
0.45
Revenue / Employee
3.29M
Employees
83
Market Cap
123.40M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 254.33M | -44.64M | -14.93% |
| Mar 31, 2024 | 298.98M | -88.60M | -22.86% |
| Mar 31, 2023 | 387.58M | -148.03M | -27.64% |
| Mar 31, 2022 | 535.61M | 187.48M | 53.85% |
| Mar 31, 2021 | 348.13M | 93.42M | 36.68% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Alfavision Overseas (India) | 13.30M |
| Supha Pharmachem | 5.27B |
| Venmax Drugs and Pharmaceuticals | 44.14M |
| Ishita Drugs and Industries | 161.68M |
| Crestchem | 266.14M |
| Vasundhara Rasayans | 315.86M |
| Bacil Pharma | 5.48M |
| Tyche Industries | 505.54M |